MedTrace Logo

Prediction of Lupus Renal Flares Study

NCT05362812 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-05-10

No results posted yet for this study

Summary

In patients with systemic lupus erythematosus, urinary CD4+ T cells may have the potential to predict subsequent renal flares in the next 6 months. Patients with systemic lupus erythematosus from our outpatient clinic will be included in this cross-sectional, prospective biomarker study regardless of disease activity, clinical phenotype, and disease duration or baseline therapy. Urinary T cells will be analyzed by flow cytometry. 6 months after sample collection a clinical follow-up will be conducted to assess the occurrence of either recurrent or de novo renal flares.

Conditions

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Philipp Enghard, MD · Department of Nephrology and Intensive Care, Charite University Hospital

  • Tobias Alexander, MD · Department of Rheumatology and Clinical Immunology, Charite University Hospital

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2023-04-01
Completion
2023-04-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05362812 on ClinicalTrials.gov